2 New Funds Join the Kiplinger 25
Baron Emerging Markets and T. Rowe Price Dividend Growth take the place of funds that have closed their doors to new investors.
In the steamy days of summer, two of the hottest members of the Kiplinger 25 closed to new investors: Harding Loevner Emerging Markets (HLEMX), which, like most of its peers, went through a rough patch in 2014 and 2015, soared 14.8% in this year’s first seven months. That clocked the average diversified developing-markets stock fund by 4.0 percentage points. Vanguard Dividend Growth (VDIGX), which has a superb long-term record, returned 7.5% year-to-date, beating the typical large-company stock fund by 1.6 percentage points.
In keeping with our custom of removing funds from the Kip 25 if they shut to new investors, we must bid farewell to these two funds. Their replacements: Baron Emerging Markets (BEXFX) and T. Rowe Price Dividend Growth (PRDGX).
The Baron fund’s manager, Michael Kass, has a solid record. From the time he launched the fund in January 2011 through July 31, it returned 3.0% annualized. That isn’t a lot, but it trounced the typical diversified emerging-markets stock fund by an average of 5.3 percentage points per year. The fund charges 1.45% annually for expenses, about average for the category.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Kass focuses on midsize to large companies with above-average growth and competitive advantages over their peers. Take Indonesia’s PT Matahari Department Store. It lets space in its stores to other merchants, who pay rent or share a percentage of their sales. The firm should benefit as more Indonesians join the middle class, says Kass.
After a nearly five-year-long bear market during which emerging-markets stocks lost 35%, on average, Kass thinks a turnaround is near. Finding good businesses at prices too low to resist, he has moved back into companies based in countries, such as Brazil and Russia, that he had avoided recently. One example: BM&F Bovespa, a Sao Paolo–based stock exchange whose stock soared 76% over the first seven months of the year. The fund holds 80 to 90 stocks, with China, India and Brazil representing its three biggest country weightings.
Given his fund’s name, it’s not surprising that Dividend Growth’s Tom Huber seeks large, sturdy firms that have the capacity to consistently raise their payouts. Pfizer (PFE), General Electric (GE) and Danaher (DHR) top the portfolio’s list of 104 stocks. A commitment to pay a dividend encourages company executives to make smart decisions, says Huber. The result, he says, is an “all-weather” fund that has beaten the market over the long haul. Since Huber took over in March 2000, Dividend Growth has returned an annualized 6.8%. That topped Standard & Poor’s 500-stock index by an average of 2.5 percentage points per year. The fund’s expense ratio of 0.64% is well below average for its category.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Nellie joined Kiplinger in August 2011 after a seven-year stint in Hong Kong. There, she worked for the Wall Street Journal Asia, where as lifestyle editor, she launched and edited Scene Asia, an online guide to food, wine, entertainment and the arts in Asia. Prior to that, she was an editor at Weekend Journal, the Friday lifestyle section of the Wall Street Journal Asia. Kiplinger isn't Nellie's first foray into personal finance: She has also worked at SmartMoney (rising from fact-checker to senior writer), and she was a senior editor at Money.
-
Stock Market Today: Stocks End Higher in Whipsaw Session
The main indexes were volatile Thursday with Nvidia earnings in focus.
By Karee Venema Published
-
Trump Picks Dr. Oz as Head of Medicare and Medicaid
President-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.
By Kathryn Pomroy Published
-
How Inflation, Deflation and Other 'Flations' Impact Your Stock Portfolio
There are five different types of "flations" that not only impact the economy, but also your investment returns. Here's how to adjust your portfolio for each one.
By Kim Clark Published
-
Kiplinger's Economic Calendar for This Week (November 18-22)
This week's relatively quiet economic calendar features several Fed speakers and a key labor market update.
By Karee Venema Last updated
-
Why I Still Won't Buy Gold: Glassman
One reason I won't buy gold is because while stocks rise briskly over time – not every month or year, but certainly every decade – gold does not.
By James K. Glassman Published
-
Should You Use a 25x4 Portfolio Allocation?
The 25x4 portfolio is supposed to be the new 60/40. Should you bite?
By Nellie S. Huang Published
-
Retirement Income Funds to Keep Cash Flowing In Your Golden Years
Retirement income funds are aimed to engineer a steady payout of cash for retirees. Here are a few we like.
By Nellie S. Huang Last updated
-
10 2024 Stock Picks From An Investing Expert
These 2024 stock picks have the potential to beat the market over the next 12 months.
By James K. Glassman Published
-
Dividends Are in a Rut
Dividends may be going through a rough patch, but income investors should exercise patience.
By Jeffrey R. Kosnett Published
-
Special Dividends Are On The Rise — Here's What to Know About Them
More companies are paying out special dividends this year. Here's what that means.
By Kim Clark Published